Table II.
Association of asthma, COPD, and diabetes comorbidity with the severity of COVID-19
| Region, country/comorbidity | Comorbidity+/− (%) |
P value∗ | ||
|---|---|---|---|---|
| Total | Nonsevere | Severe | ||
| Wuhan, China† | 548 | 279 | 269 | |
| Asthma | 5/543 (0.9) | 2/277 (0.7) | 3/266 (1.1) | .483 |
| COPD | 17/531 (3.1) | 4/275 (1.4) | 13/256 (4.8) | .019 |
| Diabetes | 83/465 (15.1) | 31/248 (11.1) | 52/217 (19.3) | .010 |
| New York, USA‡ | 1651 | 914 | 737 | |
| Asthma | 99/1552 (6.0) | 47/867 (5.1) | 52/685 (7.1) | .128 |
| COPD | 66/1585 (4.0) | 14/900 (1.5) | 52/685 (7.1) | .000 |
| Diabetes | 248/1403 (15.0) | 49/865 (5.4) | 199/538 (27.0) | .000 |
| Total | 2199 | 1193 | 1006 | |
| Asthma | 104/2095 (4.7) | 49/1144 (4.1) | 55/951 (5.5) | .111 |
| COPD | 83/2116 (3.8) | 18/1175 (1.5) | 65/941 (6.5) | .000 |
| Diabetes | 331/1868 (15.1) | 80/1113 (6.7) | 251/755 (25.0) | .000 |